Clinic-pathological variables		Frequency	Percent
Gender	male	24	53.3%
Gender	female	21	46.7%
Age group	<60 years	35	77.8%
Age group	≥60 years	10	22.2%
Tumor location	Nodal	28	62.2%
Tumor location	Extranodal	17	37.8%
Ann Arbor clinical stage	Stage I & II	33	73.3%
Ann Arbor clinical stage	Stage III & IV	12	26.7%
Tumor recurrence	yes	18	40%
Tumor recurrence	no	27	60%
Deaths	yes	9	20%
Patient response to chemotherapy	Response by <3 courses	14	31.1%
	Response by ≥3 courses	16	35.6%
	chemoresistant	15	33.3%